CapForce Inc.(CFOR.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
CapForce Inc.
CFOR.US
CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services.
1.956 T
CFOR.USMarket value -Rank by Market Cap -/-

Financial Score

09/03/2026 Update
A
BiotechnologyIndustry
Industry Ranking5/407
Industry medianC
Industry averageD
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE102.11%A
    • Profit Margin76.04%A
    • Gross Margin0.00%E
  • Growth ScoreA
    • Revenue YoY610.97%A
    • Net Profit YoY167.66%A
    • Total Assets YoY131.07%A
    • Net Assets YoY240.16%A
  • Cash ScoreB
    • Cash Flow Margin134.12%C
    • OCF YoY610.97%A
  • Operating ScoreA
    • Turnover0.99A
  • Debt ScoreA
    • Gearing Ratio19.63%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    03:15 ETgenOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model

    prnewswire·
    US
    LABU
    +7.21%
    US
    IBBQ
    +1.95%
    US
    BBH
    +2.13%
    prnewswire·
    US
    LABU
    +7.21%
    US
    IBBQ
    +1.95%
    US
    BBH
    +2.13%

    Enanta Pharmaceuticals Inc. Announces Date for Upcoming Annual Meeting of Stockholders

    Reuters·
    US
    FBT
    +1.99%
    US
    BBH
    +2.13%
    US
    SBIO
    +2.87%
    Reuters·
    US
    FBT
    +1.99%
    US
    BBH
    +2.13%
    US
    SBIO
    +2.87%

    OpGen Inc Announces Resignation of President

    TradingView·
    US
    OPGN
    0.00%
    US
    CFOR
    +2.04%
    TradingView·
    US
    OPGN
    0.00%
    US
    CFOR
    +2.04%

    OpGen Inc. Extends $9 Million Private Placement Agreement with AEI Capital

    Reuters·
    US
    OPGN
    0.00%
    US
    CFOR
    +2.04%
    Reuters·
    US
    OPGN
    0.00%
    US
    CFOR
    +2.04%

    OpGen Inc. Files Initial Statement of Beneficial Ownership for CEO Christian-Laurent Bonte

    Reuters·
    US
    OPGN
    0.00%
    US
    CFOR
    +2.04%
    Reuters·
    US
    OPGN
    0.00%
    US
    CFOR
    +2.04%
    © 2026 Longbridge｜Disclaimer